(30 days)
Not Found
No
The document does not mention AI, ML, or any related concepts in the device description, intended use, or performance studies.
No.
The device is used for monitoring physiological parameters, not for treating any condition.
No
The device is for monitoring physiological parameters, not for diagnosing medical conditions.
No
The device description explicitly states "The SureSigns VM Series Patient Monitors are for monitoring, recording and alarming of multiple physiological parameters...". This indicates a physical hardware device, not software only. The listed parameters (ECG, Respiration, NBP, SpO2, IBP, CO2, Temperature) also require hardware sensors and processing units.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The intended use is for "monitoring the physiological parameters of patients." This involves measuring parameters directly from the patient's body (ECG, NBP, SpO2, etc.).
- Device Description: The description reinforces that it's for "monitoring, recording and alarming of multiple physiological parameters of adults, pediatrics, and neonates."
- Lack of IVD Characteristics: IVD devices are designed to examine specimens (like blood, urine, tissue) in vitro (outside the body) to provide information about a patient's health. The provided information does not mention any analysis of specimens.
The device is clearly a patient monitor used for in vivo (within the body) physiological monitoring.
N/A
Intended Use / Indications for Use
Indicated for use by health care professionals whenever there is a need for monitoring the physiological parameters of patients.
Standard and optional parameters include:
·ECG ·Respiration ·NBP ·SpO2 ·IBP ·CO2 ·Temperature
The SureSigns VM Series Patient Monitors are for monitoring, recording and alarming of multiple physiological parameters of adults, pediatrics, and neonates in healthcare environments. Additionally, the monitor is intended for use in transport situations within a healthcare facility.
Product codes
MHX, DSJ, DSK, DXN, DRT, DQA, DSA, FLL, CCK
Device Description
The SureSigns VM4, VM6, and VM8 Patient Monitors are multi-parameter patient monitors that monitor, record, and alarm physiological parameters. They are designed for use by health care professionals in healthcare environments and during transport within a healthcare facility. The devices can monitor various parameters including ECG, Respiration, NBP, SpO2, IBP, CO2, and Temperature. The alarm limit range for the Heart Rate (HR) sourced from the ECG, the SP02, or the NBP measurement has been modified to allow for separate ranges for each source.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adults, pediatrics, and neonates
Intended User / Care Setting
Health care professionals; healthcare environments; transport situations within a healthcare facility.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Verification, validation, and testing activities establish the performance, functionality, and reliability characteristics of the subject devices with respect to the predicates. Testing involved system level tests, performance tests, and safety testing from hazard analysis. Pass/Fail criteria were based on the specifications cleared for the predicate device, the specifications of the subject device and test results showed substantial equivalence. The results demonstrate that the Philips SureSigns VM4, VM6 and VM8 Patient Monitors meet all reliability requirements and performance claims and supports a determination of substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K052707, K080495, K090483, K101067
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
JUHAN 1. 3 2011
510K Summary
This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21 CFR 807-92(c).
- The submitter of this pre-market notification is: 1.
Larry Milana Philips Medical Systems 3000 Minuteman Road Andover, MA 01810 United States
Tel: 978-659-7860 Fax: 978-659-3819 Email: larry.milana@philips.com
This summary was prepared on December 10, 2010.
- The names of the subject devices are the Philips SureSigns Series Patient Monitors, 2. SureSigns VM4, VM6, and VM8 Patient Monitors
-
- The trade names of the devices are the SureSigns VM4, SureSigns VM6, SureSigns VM8 Patient Monitors.
-
- The common usual name is multi-parameter patient monitor
-
- The Classification names are as follows:
| Device Panel | Classification | ProCode | Description | Applicable
Subject
Devices |
|-----------------------------------------|----------------|---------|-----------------------------------------------------------------------------|----------------------------------|
| Circulatory System
Devices | 870.1025, II | MHX | Monitor, Physiological,
Patient (with arrhythmia
detection or alarms) | VM4, VM6,
VM8 |
| | 870.1110, II | DSJ | Alarm, Blood Pressure | VM4, VM6,
VM8 |
| | 870.1110, II | DSK | Computer, Blood Pressure | VM4, VM6,
VM8 |
| | 870.1130, II | DXN | System, Measurement,
Blood Pressure, Non-
Invasive | VM4, VM6,
VM8 |
| | 870.2300, II | DRT | Monitor, Cardiac (incl.
Cardiotachometer & Rate
Alarm | VM4, VM6,
VM8 |
| | 870.2700, II | DQA | Oximeter | VM4, VM6,
VM8 |
| | 870.2900, I | DSA | Cable, Transducer and
Electrode, incl. Patient
connector | VM4, VM6,
VM8 |
| General Hospital and
Personal Use | 880.2910, II | FLL | Thermometer, Electronic,
Clinical | VM4 |
| Anesthesiology &
Respiratory Therapy | 868.1400, II | CCK | Analyzer, Gas, | VM8 |
December 10, 2010
1
-
- The modifications are as follows:
- . The alarm limit range for the Heart Rate (HR) sourced from the ECG, the SP02, or the NBP measurement has been modified to allow for separate ranges for each source. This modification allows the device to offer a wider heart rate (pulse) measurement range for the ECG and SP02 sources while keeping the existing NBP range.
- . Modification of the current Indications for Use to include a list of the measurements the device can perform. The Indications for Use will now read as follows:
Indicated for use by health care professionals whenever there is a need for monitoring the physiological parameters of patients.
Standard and optional parameters include:
·ECG ·Respiration ·NBP ·SpO2 ·IBP ·CO2 ·Temperature
-
- The subject devices have the same Intended Use as the legally marketed predicate device :
"The SureSigns VM Series Patient Monitors are for monitoring, recording and alarming of multiple physiological parameters of adults, pediatrics, and neonates in healthcare environments. Additionally, the monitor is intended for use in transport situations within a healthcare facility".
- The subject devices have the same Intended Use as the legally marketed predicate device :
-
ഗ് The subject devices have the same fundamental technological characteristics as the legally marketed predicate devices. The subject devices use the same design as the predicate devices. The change to heart rate does not change the fundamental characteristics.
-
- Verification, validation, and testing activities establish the performance, functionality, and reliability characteristics of the subject devices with respect to the predicates. Testing involved system level tests, performance tests, and safety testing from hazard analysis. Pass/Fail criteria were based on the specifications cleared for the predicate device, the specifications of the subject device and test results showed substantial equivalence. The results demonstrate that the Philips SureSigns VM4, VM6 and VM8 Patient Monitors meet all reliability requirements and performance claims and supports a determination of substantial equivalence.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal features a stylized eagle with three lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
JAN 1 3 2011
Philips Medical Systems c/o Mr. Lawrence Milana Regulatory Engineer 3000 Minuteman Road Andover, MA 01810
Re: K103652
Trade/Device Name: SureSigns VM4, SureSigns VM6, SureSigns VM8 Regulation Number: 21 CFR 870.1025 Regulation Name: Monitor, Physiological, Patient (with arrhythmia detection or alarm) Regulatory Class: Class II Product Code: MHX Dated: December 10, 2010 Received: December 14, 2010
Dear Mr. Milana:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
.
,
・・・・・・
:
3
Page 2 - Mr. Lawrence Milana
Please be advised that FDA 's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
W.M.d.
3 Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
103652
Indications for Use
JAN 1 3 2011
510 (k) Number (if known): K103652
Device Name: SureSigns VM4 (reference number: 863063) SureSigns VM6 (reference numbers: 863064, 863065) SureSigns VM8 (reference numbers: 863066, 863068)
Indications for Use:
Indicated for use by health care professionals whenever there is a need for monitoring the physiological parameters of patients.
Standard and optional parameters include:
·ECG
- ·Respiration
- •NBP
- ·SpO2
- •IBP
- ·CO2
- ·Temperature
Prescription Use: YES AND/OR over-the-counter Use: NO (Part 21 CFFFR 801 Subpart D) (21 CFR 807 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CORH, Office of Device Evaluation (ODE)
W.M.
ivision Sign-Off) Division of Cardiovascular Devices
Page 1_of 1
510(k) Number
December 10, 2010
Page 22 of 68